Evidence map›Paper›PMID 29679545›Full record

ArticleThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

The impact of ocular tuberculosis on vision after two months of intensive therapy.

Suzana Batista Vereza de Oliveira, Ângelo Ferreira Passos, David Jamil Hadad, Lorena Zbyszynski, Pedro Sousa de Almeida Júnior, Luiz Guilherme Schmidt Castellani, Reynaldo Dietze, Moisés Palaci

Open access · goldAbstract read
In one paragraph

Article in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. [Treatment of ocular tuberculosis-an update].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Suzana Batista Vereza de OliveiraUniversidade Federal do Espírito Santo, Hospital Universitário Cassiano Antônio de Moraes, Departamento de Oftalmologia, Vitória, ES, Brazil.
Ângelo Ferreira PassosUniversidade Federal do Espírito Santo, Hospital Universitário Cassiano Antônio de Moraes, Departamento de Oftalmologia, Vitória, ES, Brazil.
David Jamil HadadUniversidade Federal do Espírito Santo, Núcleo de Doenças Infecciosas, Vitória, ES, Brazil.
Lorena ZbyszynskiUniversidade Federal do Espírito Santo, Hospital Universitário Cassiano Antônio de Moraes, Departamento de Oftalmologia, Vitória, ES, Brazil.
Pedro Sousa de Almeida JúniorUniversidade Federal do Espírito Santo, Núcleo de Doenças Infecciosas, Vitória, ES, Brazil.
Luiz Guilherme Schmidt CastellaniUniversidade Federal do Espírito Santo, Núcleo de Doenças Infecciosas, Vitória, ES, Brazil.
Reynaldo DietzeUniversidade Federal do Espírito Santo, Núcleo de Doenças Infecciosas, Vitória, ES, Brazil.
Moisés PalaciUniversidade Federal do Espírito Santo, Núcleo de Doenças Infecciosas, Vitória, ES, Brazil. Electronic address: mpalaci@ndi.ufes.br.
Universidade Federal do Espírito Santo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis is an infectious disease of global importance with major economic and social burden accounting for 25% of all avoidable deaths in developing countries. Extrapulmonary involvement may occur either in association with clinically apparent pulmonary tuberculosis or in isolation. This cross-sectional descriptive study aimed to evaluate the impact of ocular tuberculosis in visual acuity at baseline and after two months of intensive anti-tuberculous therapy. A sample of 133 pulmonary tuberculosis patients, seven disseminated tuberculosis, and three pleural tuberculosis patients was evaluated. All patients underwent routine ophthalmic evaluation, including assessment of visual acuity, biomicroscopy, applanation tonometry, indirect ophthalmoscopy, and fluorescent angiography as appropriate. None of the patients had impaired visual acuity due to tuberculosis. A rate of 4.2% (6/143) of ocular involvement was found. None of the patients with ocular involvement were HIV-infected. Of the six patients with ocular involvement, five met the diagnostic criteria for probable and one for possible ocular lesions. As for the type of ocular lesions, two patients had bilateral findings: one had sclerouveitis and the second had choroidal nodules. The other four patients presented with unilateral lesions: peripheral retinal artery occlusion in the right eye (one case), choroidal nodules in the left eye (one case), and choroidal nodules in the right eye (two cases). Patients progressed favorably after two month of intensive therapy, with no significant reduction in vision.

Indexed as

AdolescentAdultAgedAntitubercular AgentsCross-Sectional StudiesEthambutolFemaleHumansIsoniazidMaleMiddle AgedPyrazinamideRifampinStatistics, NonparametricTreatment OutcomeTuberculosis, OcularAntitubercular AgentsEthambutolIsoniazidPyrazinamideRifampinEyeTreatmentTuberculosisVisual acuity

Identifiers

PMID29679545
PMCPMC9425680
OpenAlexW2802978260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.